A Long-Term, Open-Label Extension Study to Investigate the Long-Term Safety of SYR110322 (SYR-322) in Subjects with Type 2 Diabetes
- Registry ID
- EUCTR2005-004672-20
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Takeda Global Research & Development Center, Inc.,
- Start date
- 2006-04-24
- Last update
- 2026-08-16
Conditions
- Type II diabetes mellitus
- Type II diabetes mellitus.
Summary
• To evaluate the safety of SYR-322 administered alone or in combination with a sulfonylurea, metformin, a thiazolidinedione, or insulin by evaluating adverse events (AEs), clinical laboratory parameters, electrocardiogram (ECG) readings, vital sign measurements, oral temperature, physical examinations, and hypoglycemic events
Locations
- , , Estonia
- , , Slovakia
- , , Czechia
- , , Latvia
View on source registry